R.N. Ün, et al.
Phytochemistry176(2020)112404
Table 3
IC50 (μM) values of compounds 1–6 and doxorubicin on treated cell lines.a.
Compound
A549
HEK293
Hela
MCF7
PC3
1
> 50
> 50
0.21
0.12
3.25
8.57
0.09
0.17
> 50
> 50
> 50
> 50
> 50
> 50
> 50
0.24
45.59
> 50
42.92
10.23
23.58
45.68
19.68
1.73
2.32
> 50
> 50
> 50
> 50
> 50
> 50
> 50
6.43
0.52
0.16
1.51
2
> 50
> 50
> 50
8.12
3
0.02
0.01
0.09
1.10
0.01
0.02
1.77
0.43
3.15
4.37
1.69
4
5
6
2.34 + 0.61
> 50
azukisaponin IV
Doxorubicin
0.05
0.08
0.38
14.88
0.23
a
Data are expressed as the mean values
SD of three experiments.
1, 2, 4 and 6 are characterized by the presence of an aldehyde group
and a carboxyl group at C-23 and C-28, respectively. Their peculiarity is
in the occurrence of further secondary alcoholic functions at positions
21 or 22.
3.3. Extraction and isolation procedure
The air-dried and powdered plant material (S. odontopetala; whole
plant, 500 g) was first extracted with n-Hexane (2 × 3 L), CH2Cl2
(2 × 3 L) and MeOH (3 × 4 L) at room temperature. After carrying out
filtration and evaporation procedures, n-Hexane (5.8 g), CH2Cl2 (8.4 g)
and MeOH (71.0 g) extracts were obtained, respectively. The MeOH
extract (71.0 g) was dissolved in H2O (500 mL) and successively par-
titioned with n-Hexane (2 × 200 mL), CH2Cl2 (2 × 200 mL) and n-
BuOH saturated with H2O (3 × 300 mL). The n-BuOH phase (15.0 g)
was subjected to a MPLC using reverse-phase material (Lichroprep. RP-
18, 25–40 mm, 300.0 g) eluting with H2O:MeOH (100:0–0:100) to give
5 main fraction (1–5).
Naturally occurring oleanane saponins have been reported to show
anticancer effect through various pathways, such as antimetastasis,
lines, including PC-3 (prostate carcinoma cells), MCF-7 (breast cancer
cells), A549 (alveolar basal carcinoma cells), HeLa (cervical carcinoma
cells), an MTT assay, detecting the activity of mitochondrial reductase
of viable cells, was performed. The achieved results showed that com-
pounds 1–6 isolated from S. odontopetala inhibited cell viability in a
dose-dependent manner with IC50 values in a range of 0.09–45.68 μM.
The IC50 values for all affected cell lines are shown in Table 3. Azuki-
saponin IV and compound 4 showed significant activity as compared to
positive control, doxorubicin, against A549 cell line. All isolated com-
pounds did not exhibit any activity at the tested concentrations on
MCF7 cells and showed moderate cytotoxic activity against HeLa cells.
Compounds 1, 5 and 6 showed more than twenty-eight fold, twice-fold
and six fold activity than doxorubicin against PC3 cell line, respec-
tively. In addition, the cytotoxic activity of compounds 1–6 against a
normal cell line HEK-293 was tested. None of the tested compounds
exhibited activity against this cell line.
Fraction 1 (3.0 g) was subjected to silica gel (Merck. 7734, 250.0 g)
column chromatography with the solvent system CH2Cl2:MeOH:H2O
(90:10:1) to give 7 sub-fractions (1a-1g). The sub-fraction 1 b (30.0 mg)
was subjected to a MPLC using reverse-phase material (RP-18, 50.0 g)
eluting with H2O:MeOH (1:1) to give compound 6 (1.7 mg). Fraction 1e
(95.8 mg) was submitted to silica gel (Merck. 7734, 250 g) column
chromatography with the following solvent system CH2Cl2:MeOH:H2O
(80:20:2–70:30:3) to give sub-fraction 1e1 and 1e1 (37.0 mg) was
subjected to MPLC (RP-18, 5.0 g) eluting with H2O:MeOH (1:1) to give
azukisaponin IV (2.5 mg). Fraction 1 d (339.0 mg) was applied to silica
gel (Merck. 7734, 250.0 g) column chromatography with the solvent
system CH2Cl2:MeOH:H2O (80:20:2) to give sub-fraction 1d1 and 1d1
(27.0 mg) was subjected to MPLC (RP-18, 5 g) eluting with H2O:MeOH
(3:2) to give compounds 1 (5.9 mg) and 3 (1.4 mg). Fraction 1f
(43.7 mg) was applied to silica gel (Merck. 7734, 90.0 g) column
chromatography with the solvent system CH2Cl2:MeOH:H2O (70:30:3)
to give sub-fraction 1f2 and 1f2 (27.0 mg) was subjected to MPLC (RP-
18, 5.0 g) eluting with H2O:MeOH (7:3) to give compounds 4 (2.3 mg)
and 5 (3.5 mg).
3. Materials and methods
3.1. General procedures
Optical rotations were measured on a Autopol IV (Rudolph Research
Analytical) polarimeter. IR measurements were obtained with a Bruker
IFS-48 spectrometer. NMR experiments were acquired in methanol-d4
(99.95%, Sigma-Aldrich) with a Bruker DRX-600 spectrometer (Bruker
BioSpin GmBH, Rheinstetten, Germany) equipped with a Bruker 5 mm
TCI CryoProbe at 300 K. Data processing were carried out with Topspin
3.2 software. The ROESY spectra were acquired with tmix = 400 ms. GC
analyses were performed on a Termo Finnigan Trace GC apparatus
using a l-Chirasil-Val column (0.32 mm × 25 m). HRESIMS data were
acquired on an LTQ Orbitrap XL mass spectrometer (Thermo Fisher
Scientific, San Jose, CA, USA) operating in negative ion mode.
Fraction 3 (590.0 mg) was subjected to silica gel (Merck. 7734,
30.0 g) column chromatography with the solvent system
CH2Cl2:MeOH:H2O (90:10:1–80:20:2) to give 4 sub-fractions (3a-3d).
The sub-fraction 3 d (21.0 mg) was subjected to a Sephadex (LH-20
Amersham Biosciences) column with MeOH to give compound 2
(1.0 mg).
The extraction and isolation procedure has been repeated to afford
the required amount of each compound for further chemical and bio-
logical analyses.
3.4. 3β,22α-dihydroxyolean-12-en-23-al-28-oic acid 3-O-α-L-
3.2. Plant material
arabinopyranosyl-(1 → 3)-β-D-glucuronopyranoside (1)
Whole plants of Silene odontopetala Fenzl. (Caryophyllaceae) were
collected from Malatya Darende Ağılbaşı, 1600 m, Turkey (GPS co-
ordinates 38°32′52.0"N; 37°50′49.3"E) in May 2010, and identified by
Serdar G. Şenol (Department of Biology, Faculty of Science, Ege
University, İzmir, Turkey). In the Herbarium of Ege University (EGE-
HERB 42722) a voucher specimen has been deposited.
Amorphous white solid; C41H62O15; [α]2D5 +8.7 (c 0.1 MeOH); IR
KBr
ν
cm−1: 3430, 2925, 1650, 1615; for 1H and 13C NMR (methanol-d4,
max
793.4006 (C41H61O15, 793.4010).
6